Description
Invokamet is made up of two medications, canagliflozin and metformin hydrochloride. It's used with diet and exercise to treat adults with type 2 diabetes. Canagliflozin is used to decrease the risk of serious cardiovascular events in adults with type 2 diabetes and heart disease and the risk of end-stage kidney disease, doubling serum creatinine levels, death caused by cardiovascular reasons, and hospitalization for adults with type 2 diabetes, heart failure, and diabetic kidney disease with the presence of albumin in the urine.
Invokamet should not be used to treat adults with type 1 diabetes as this may increase their risk for a serious condition called diabetic ketoacidosis.
Fact Table |
Formula |
C24H25FO5S |
License |
US DailyMed, EU EMA |
Bioavailability |
65% |
Legal status |
Rx-Only |
Chemical Name |
Canagliflozin/metformin |
Elimination half-life |
10–13 hours |
Dosage (Strength) |
50/1000mg, 50/500mg, 150/1000mg, 150/500mg |
Pregnancy |
Not recommended |
Brands |
Invokamet |
Protein binding |
99% |
PubChem CID |
24812758 |
MedlinePlus |
a613033 |
ChEBI |
73274 |
ATC code |
A10BK02 |
DrugBank |
DB08907 |
KEGG |
D09592 |
Routes of administration |
By mouth |
Directions
Follow your doctor's instructions and read the information that comes with your Invokamet prescription. Don't hesitate to reach out to your doctor or pharmacist with any questions or concerns you have.
Invokamet oral tablets are available in the following strengths:
- Canagliflozin 50 mg and metformin HCl 500 mg
- Canagliflozin 50 mg and metformin HCl 1,000 mg
- Canagliflozin 150 mg and metformin HCl 500 mg
- Canagliflozin 150 mg and metformin HCl 1,000 mg
The recommended starting dose is Invokamet (canagliflozin 50 mg and metformin 500 mg) by mouth two times a day with meals. The dose may be adjusted based on kidney function and response to the medication.
Ingredients
Each Invokamet tablet contains canagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide. Inactive ingredients include croscarmellose sodium, hypromellose, magnesium stearate, and microcrystalline cellulose. The film-coating is made of macrogol/PEG3350, polyvinyl alcohol (hydrolyzed partially), talc, titanium dioxide, iron oxide yellow (50 mg/1,000 mg and 150 mg/500 mg tablets), iron oxide red (50 mg/1,000 mg, 150 mg/500 mg, and 150 mg/1,000 mg tablets), and iron oxide black (150 mg/1,000 mg tablets).
Contraindications
Do not take Invokamet if you have severe kidney problems or if you are on dialysis.
Do not take Invokamet if you have metabolic acidosis such as diabetic ketoacidosis.
Do not take Invokamet if you are allergic to canagliflozin, metformin, or any of the other ingredients or excipients contained in Invokamet.
Cautions
WARNING: LACTIC ACIDOSIS
See full prescribing information for complete boxed warning.
- Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio; and metformin plasma levels generally greater than 5 mcg/mL.
- Risk factors include renal impairment, concomitant use of certain drugs, age greater than 65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, and hepatic impairment. Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information.
- If lactic acidosis is suspected, discontinue INVOKAMET/INVOKAMET XR and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended.
|
- Before you start treatment with Invokamet, be sure to discuss the following with your doctor:
- All the medications you take, including prescription and over-counter-medications as well as vitamins and herbal supplements.
- Your allergies
- Your medical history and current health problems
- If you are pregnant or have plans to become pregnant
- If you are breastfeeding or have plans to breastfeed
- If you have any upcoming imaging procedures
- Risk of lower limb amputations has been associated with canagliflozin. Talk to your doctor about your risk factors for lower limb amputations before you start taking Invokamet. Call your doctor right away if you have pain, tenderness, sores, or ulcers on your feet.
- Volume depletion can occur during treatment with Invokamet. Your risk may be greater if you have kidney problems, are elderly, or if you take certain fluid pills.
- Ketoacidosis, a severe condition that can be fatal, can occur with the use of Invokamet. Seek emergency care right away if you have nausea, vomiting, stomach pain, general discomfort, and trouble breathing.
- Urinary tract infections and kidney infections that may require hospitalization can occur with the use of Invokamet. Contact your doctor right away if you have burning upon urination, frequent urination, urination that looks cloudy, bright pink, or red, urine with a strong odor, pelvic pain, fever, nausea, or back pain.
- Low blood sugar can occur with the use of Invokamet, especially if taken with insulin or other medications that can lower blood sugar. Monitor your blood sugar and treat low blood sugar as your doctor has instructed.
- Although rare, necrotizing fasciitis of the perineum (Fournier's gangrene), a severe and potentially fatal necrotizing infection that warrants surgery, can occur during treatment with Invokamet. Seek emergency care right away if you have fever or discomfort and pain, tenderness, redness, or swelling in the general or perineal area.
- Genital fungal infections can occur during treatment with Invokamet.
- Serious allergic reactions can occur with the use of Invokamet. Seek emergency care right away if you have a rash, rapid heart rate, trouble breathing, or swelling of your face, lips, tongue, or throat.
- Treatment with Invokamet can increase your risk of bone fractures.
- Treatment with Invokamet can decrease your vitamin B12 levels.
Side Effects
Like with any medication, Invokamet can cause side effects. Although the most common Invokamet side effects are genital fungal infections in women, urinary tract infections, frequent urination, diarrhea, nausea, vomiting, gas, weakness, indigestion, stomach discomfort, and headache, they are not all the possible side effects that can occur during treatment.
Call your doctor right away if you have side effects that bother you or won't go away.
Reference:
- Invokamet (canagliflozin and metformin hydrochloride tablets), for oral use. Titusville, NJ: Janssen Pharmaceuticals, Inc.; 2020.
About Dr. Savannah Muncy (Page Author)
Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13242